This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Oxford University Innovation Ltd, Isis Innovation Limited, Imaxio Sa. Active years: 2007-2025.
Location History:
- Reading, GB (2007)
- Headington, GB (2016 - 2018)
- Oxford, GB (2015 - 2024)
- Oxfordshire, GB (2022 - 2024)
Company Filing History:
7 out of 483 
3 out of 330 
1 out of 1 Years Active: 2007-2025
Title: The Innovations of Matthew Guy Cottingham
Introduction
Matthew Guy Cottingham is a prominent inventor based in Oxford, GB. He has made significant contributions to the field of medicine through his innovative work in recombinant adenoviral vectors. With a total of 10 patents to his name, Cottingham's inventions are paving the way for advancements in medical treatments.
Latest Patents
Among his latest patents, Cottingham has developed a recombinant adenoviral vector that provides immunogenic compositions and their uses in medicine. This invention specifically includes an adenoviral vector that comprises the genome of an adenovirus other than AdHu5 and AdY25. The genome has been modified to lack the native E4 locus of the adenovirus while incorporating heterologous E4Orf1, E4Orf2, and E4Orf3 coding regions from AdY25. This innovative approach enhances the potential applications of adenoviral vectors in therapeutic settings.
Career Highlights
Cottingham has worked with notable organizations such as Oxford University Innovation Limited and Isis Innovation Limited. His career is marked by a commitment to advancing medical technology and improving patient outcomes through innovative research and development.
Collaborations
Throughout his career, Cottingham has collaborated with esteemed colleagues, including Sarah C. Gilbert and Adrian Vivian Sinton Hill. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking inventions